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ABSTRACT 
The Memory Complaints Inventory (MCI) is a self-report questionnaire developed by 
Paul Green to provide further effort-related evidence in neuropsychiatric practice. It is 
comprised of nine subscale scores, in addition to the imbedded Plausible and Implausible 
symptom validity scales. The current study utilized archival MCI scores in dementia 
populations to determine the presence of, and difference between, genuine memory 
impairment profiles in separate subgroups of cognitive impairment. The study sample 
consisted of 244 adults presenting to an outpatient neuropsychology practice for 
evaluation of memory impairment. The diagnostic categories of the sample consisted of 
Alzheimer’s Disease (n = 21), Vascular Dementia (n = 33), Mild Cognitive Impairment 
(n = 53), Pseudodementia (n = 88), and Poor Effort (n = 49). Results indicated significant 
differences in all twelve one-way ANOVAs to represent differences between subgroups 
on each memory-related subscale of the MCI, the overall MCI score, and the imbedded 
Plausible and Implausible validity scales. Post-hoc analyses revealed large differences 
between the dementia categories and the Poor Effort subgroup, providing further 
evidence for the use of the MCI as a symptom validity measure due to its ability to 
differentiate between poor effort and genuine neurological impairment. Further support 
of the study’s findings would result in reliable genuine memory impairment profiles to 
provide further diagnostic and prognostic specificity in general medical practice settings. 
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1 
INTRODUCTION 
 
Memory complaints are an inevitable part of neuropsychiatric practice.  The 
validity of subjective memory complaints, however, has been widely disputed, as many 
reported memory complaints do not resemble the resulting diagnosis.  Some individuals 
will claim severe difficulty in daily memory tasks, yet receive a diagnosis of mild 
cognitive impairment, while others report few, if any, memory difficulties, yet a 
diagnosis of dementia, Alzheimer’s type is warranted.  Graham, Emery, and Hodges 
(2004) suggest distinctive cognitive profiles among unique dementia populations, which 
facilitate more effective diagnoses.  For example, the inability to recognize specific 
deficits that are evident to clinicians or caregivers (anosognosia) has been widely 
prevalent in Alzheimer’s patients, however, the frequency of individuals with 
anosognosia in mild cognitive impairment is nearly absent (Orfei et al., 2010).  Further, 
cognitive performance should be considered in differing neuropsychiatric profiles, as 
executive deficits are more prominent in individuals with subcortical ischaemic vascular 
disease, and episodic memory deficits are more prominent in individuals with 
Alzheimer’s Disease (Graham, Emery, & Hodges, 2004; Jokinen et al., 2006).  Clearly, 
differing diagnostic categories suggest divergent neuropsychiatric profiles, as well as 
divergent subjective memory complaints. 
Given each subgroup of dementia produces a unique neurocognitive profile, 
subjective memory complaints may not be an accurate depiction of an individual’s 
specific diagnosis.  One study found subjective memory complaints displayed an 
uncertain relationship with objective memory performance, creating a heightened rate of 
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false positive and false negative diagnoses (Lenehan, Klekociuk, & Summers, 2012).  In 
a study by Thompson, Henry, Rendell, Withall, and Brodaty (2015), a self-report and an 
informant-report of prospective memory difficulties were given to family members and 
individuals with dementia or mild cognitive impairment, and results indicated that neither 
self-report nor informant-report accurately measured prospective memory impairments.  
However, many studies have found subjective memory complaints highly correlated with 
the prediction of the onset of dementia (Luck et al., 2015; Mitchell, Beaumont, Ferguson, 
Yadegarfar, & Stubbs, 2014; Waldorff, Siersma, Vogel, & Waldemar, 2012).  Although 
subjective memory complaints are idiosyncratic and inconsistent with current cognitive 
impairment, much of the literature suggests that the perceived memory impairments 
continue to have high predictive validity of diagnostic outcome (L. M. Reid & 
Maclullich, 2006). 
Though subjective memory complaints have been studied extensively among 
dementia subgroups, relatively little research has been directed towards examining a 
normative-group model of measuring subjective memory complaints among these 
populations.  For example, the Memory Complaint Questionnaire (MAC-Q) is a brief 
measure of subjective memory complaints in individuals with “normal” cognitive 
functioning, but it is greatly influenced by affective states (M. Reid et al., 2012).  The 
Subjective Memory Complaints Questionnaire (SMCQ) consists of subjective memory 
complaints for general and every day memory, however, Duman, Ozel-Kizil, Baran, 
Kirici, and Turan (2011) found that the SMCQ tends to correlate with depressive 
symptoms (Youn et al., 2009).  The Memory Complaint Scale (MCS) differentiates 
demented elderly adults from normal elderly adults by identifying types of memory 
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complaints, however, more research is needed to replicate the findings (Vale, Balieiro, & 
Silva-Filho, 2012).  Amid the multitude of questionnaires created to assess subjective 
memory complaints, there are virtually no normative comparison samples of clinical 
memory disorders for objective evaluation of the subjective memory complaints.  This 
lack of data creates inconsistency in the weight of responses to subjective memory 
questions, as well as difficulty in differentiating those with true memory impairment and 
those who are malingering or those with true psychological distress, rather than 
neurocognitive distress. Specifically, those who exaggerate memory complaints in the 
self-reported memory questionnaires often perform poorly for external gain, presenting 
themselves in a negative manner, rather than due to genuine neurological impairment. For 
example, some individuals may exaggerate their memory impairment as a method of 
obtaining disability. Further, detection of malingering or determining specificity of 
diagnostic categories of dementia is largely impossible during the rapid and brief 
assessment conducted in a general medical practice due to the use of short general 
measures of cognitive functioning, such as the Mini Mental Status Exam (MMSE), the 
Saint Louis University Mental Status (SLUMS) exam, and the Montreal Cognitive 
Assessment (MOCA), in addition to subjective self-report. A specific assessment that 
encompasses validity subscales and an overall measure of memory impairment may be 
useful for general medical practice as informative of treatment planning and prognosis 
indicators for both the patient and family members or loved ones.  
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Memory Complaints Inventory 
The Memory Complaints Inventory (MCI) is a standardized self-report measure 
of subjective memory complaints that simultaneously functions as a symptom validity 
test (SVT), developed by Green (2004). The MCI consists of 58 items, divided into nine 
separate categories. These categories include: General Memory Problems (GMP), 
Numerical Information Processing and Memory Problems (NIP), Visual-Spatial Memory 
Problems (VSMP), Verbal Memory Problems (VMP), Pain Interferes with Memory 
(PIM), Memory Interferes with Work (MIW), Impairment of Remote Memory (IRM), 
Amnesia for Complex Behavior (ACB), and Amnesia for Antisocial Behavior (Green, 
2004). The MCI also contains Plausible and Implausible scales which inherently 
establishes a symptom validity test by portraying elevations on the Implausible scale 
when patients answer questions related to poor effort in a way that would not be 
consistent with genuine impairment, even in severe traumatic brain injury populations 
(Green, 2004).  Therefore, if an individual scores high on the MCI overall, as well as the 
Implausible scales, it is likely that he or she may be exaggerating their memory 
impairment.  The MCI has high reliability ( = 0.93) for all nine scales, as well as high 
internal reliability, assessed by split-thirds reliability standards (Green, 2004). 
The MCI is administered via computer and presents two non-memory related 
questions for practice about eating fresh vegetables and drinking tea or coffee. The 
individual is asked to rate how well the statement describes their experience within the 
last month. The MCI consists of a Likert Rating Scale style which ranges from 0 to 4 (0 = 
not at all true, 1 = a little true, 2 = moderately true, 3 = quite a bit true, 4 = extremely 
true). After the results are obtained, the program will generate a report based on 
5 
comparisons used in the sample population which was used to construct the MCI and 
there is an option to observe the patients’ scores with the best fit comparison group.  
The MCI was originally created as a symptom validity test to facilitate clinicians 
in identifying symptom exaggeration by means of self-report and to correlate with the 
Minnesota Multiphasic Personality Inventory – Second Edition – Restructured Form 
(MMPI-2-RF) scales of validity (Green, 2004). The MCI then provides evidence of 
symptom exaggeration in self-reports in neuropsychological settings. Paul Green’s 
previous assessment instruments have primarily encompassed performance validity tests 
(PVTs), which rely on an individual’s performance compared to a normative sample, to 
assess symptom exaggeration in patients’ functioning, rather than patients’ self-report of 
their current functioning. Therefore, the MCI, as a self-report measure of symptom 
validity correlates highly with performance on PVTs (Armistead-Jehle, Gervais, & 
Green, 2012b). 
Previous research with the MCI has mainly focused on performance validity test 
presentation only, as well as disability-assessment in clinical practice.  A study by 
Armistead-Jehle et al. (2012b) assessing individuals seeking disability status found as 
scores on performance validity tests (PVTs) decreased, scores on the MCI, a symptom 
validity test (SVT) increased.  The authors also found non-significant correlations 
between self-reported memory impairments and objective measures of memory 
performance in a disability seeking sample (Armistead-Jehle et al., 2012b). These 
findings indicate how a possible gain from a psychological evaluation can pose as a 
harmful factor on the efficacy of subjective memory complaints in neuropsychological 
practice, as scores reflect inflated symptomology as opposed to true levels of memory 
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impairment (Armistead-Jehle et al., 2012b).  As a result of those findings, Armistead-
Jehle, Gervais, and Green (2012a) conducted a study investigating PVTs in a clinical 
sample that appeared absent of external gain. Their results indicated similar findings as 
the previous study supporting the inverse relationship between MCI scores and PVT 
scores, however, the Amnesia for Complex Behavior (ACB) and Amnesia for Antisocial 
Behavior (AAB) scales were not as strongly correlated with PVT scores as the previous 
study suggested (Armistead-Jehle et al., 2012a).  The ACB and AAB scales are built into 
the MCI to determine Implausible memory complaints, and ACB and AAB are not 
typically elevated, even in neurologically impaired populations. The results indicated 
these select scales (ACB and AAB) may not discriminate between those who appeared to 
have external gain and those who appeared without external gain (Armistead-Jehle et al., 
2012a).   
Furthermore, Armistead-Jehle, Grills, Bieu, and Kulas (2016) conducted a study 
to evaluate the MCI to determine classification statistics in relation to the Medical 
Symptom Validity Test (MSVT), the Non-Verbal Medical Symptom Validity Test (NV-
MSVT), the Personality Assessment Inventory (PAI), and the Minnesota Multiphasic 
Personality Inventory-II-Restructured Form (MMPI-2-RF).  Their results found that 
individuals displayed elevated MCI scores on all scales when they failed the MSVT and 
the NV-MSVT, as well as when individuals elevated validity scales on the PAI and the 
MMPI-2-RF (Armistead-Jehle et al., 2016).  These findings support the use of the MCI as 
a self-report measure of symptomology by showing high classification statistics in 
relation to SVTs and Performance Validity Tests (PVTs) (Armistead-Jehle et al., 2016). 
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Consistent with previous research, the current study focused on MCI profiles in a 
clinical sample of patients presenting to a neuropsychological practice for reported 
memory impairment. The researchers postulated that the MCI scale profiles would 
therefore be consistent with the cognitive profile of the dementia subgroups. As a result, 
the reported memory difficulties of the sample is predicted to have an inverse relationship 
with the severity of the disorder. In terms of severity of memory impairment, the current 
study focused on four subgroups of dementia, comprised of Alzheimer’s Disease, 
Vascular Dementia, Mild Cognitive Impairment, and Pseudodementia, as well as a group 
classified with Poor Effort to further explore the MCI as a symptom validity test. 
 
Alzheimer’s Disease 
Alzheimer’s Disease is a well-known diagnosis in our contemporary medical and 
social terminology. The Alzheimer’s Foundation of America (2016) estimates that as 
many as 5.1 million Americans may currently meet criteria for an Alzheimer’s Disease 
diagnosis, and the incidence of the disease is rising as the population is living longer.  
Currently, 1.5% of the population is affected, however, as our older population continues 
to increase, estimates suggest that 20% of Americans will be affected by the disorder by 
the year 2050 (Alzheimers Foundation of America, 2016). The prevalence of the disorder 
has produced an abundance of research on the topic, creating the development of a 
typical neurocognitive profile of an individual diagnosed with Alzheimer’s Disease. A 
diagnosis of Alzheimer’s Disease subsumes a number of factors related to the disorder, 
including significant cognitive deficits, anosognosia, impaired activities of daily living 
(ADL), and a newfound necessity of a caretaker. 
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The American Psychiatric Association (2013) defines an Alzheimer’s Disease 
diagnosis in the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-
5) as having an insidious onset and gradual progression of impairment in one or more 
cognitive domains, with evidence of a causative Alzheimer’s disease genetic mutation 
(obtained by genetic testing or family history), evidence of memory and learning decline, 
accompanied by decline in at least one other cognitive domain, progressive and gradual 
decline in cognition, and no evidence of mixed etiology (American Psychiatric 
Association, 2013). Cognitive domains affected by the progression of Alzheimer’s 
Disease can include memory, language, attention, executive functioning, and visuospatial 
functioning (Caccappolo-Van Vliet et al., 2003). Research by Smits et al. (2015) posited 
that individuals diagnosed with Alzheimer’s Disease demonstrated decline in all 
cognitive domains after a 1.5-year follow-up, with memory displaying the most 
impairment in comparison with other dementia subgroups. 
In addition to cognitive deficits produced by Alzheimer’s Disease, anosognosia is 
a primary factor related to the disorder. Anosognosia exists among a continuum and is 
not domain specific. A review of the literature suggests a positive correlation between 
anosognosia and the progression of cognitive decline (Clare, Wilson, Carter, Roth, & 
Hodges, 2004; Ecklund-Johnson & Torres, 2005; Lehrner et al., 2015). Further, 
anosognosia is associated with higher age, a decreased number of depressive symptoms, 
and self-reported functional impairment (Lehrner et al., 2015). Impaired insight was 
equally represented in a comparison of amnesic mild cognitive impairment and mild 
Alzheimer’s Disease patients (Vogel et al., 2004). These results advance the Lehrner et 
al. (2015) findings, as it can be assumed that the progression from amnesic mild cognitive 
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impairment comes slightly before a diagnosis of mild Alzheimer’s Disease, meaning that 
the two groups should be relatively similar in anosognosia symptomology.   
Much like anosognosia and cognitive functioning, functional impairment or 
impairment in independent activities of daily living (IADL) exists on a non-domain 
specific continuum, and has been found to increase with the progression of Alzheimer’s 
Disease (Galasko et al., 2005).  A number of factors are thought to contribute to and 
affect ADLs, including executive function deficits, depression, and fine motor abilities.  
Executive functions, according to Barry (2012), are a set of cognitive abilities that 
regulate other abilities, such as goal-directed behavior, planning future behavior, 
anticipating outcomes, adapting to situations, forming concepts, and thinking abstractly.  
A correlational meta-analysis posits that executive functioning is associated with 
functional abilities, while also suggesting that an increase in age and Mini Mental Status 
Exam (MMSE) scores with significant executive dysfunction may result in higher 
functional impairment than executive dysfunction alone (Martyr & Clare, 2012). Tekin, 
Fairbanks, O’Connor, Rosenberg, and Cummings (2001) support the previous findings of 
the correlation between executive dysfunction and impaired IADLs, however, the results 
of their study maintained that functional impairment resulting from executive dysfunction 
and/or psychiatric symptoms may be mediated by frontal lobe dysfunction which is 
inherent in all Alzheimer’s Disease patients.  While many studies have found an 
association between depression and functional impairment in individuals with 
Alzheimer’s Disease (Payne et al., 1998; Starkstein, Jorge, Mizrahi, & Robinson, 2005), 
Tekin et al. (2001) did not support a relationship between the two constructs.  However, 
the authors found strong correlations between psychosis, agitation, anxiety, apathy, and 
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aberrant motor behavior, and explain their lack of an association due to their 
measurement of the apathy construct (Tekin et al., 2001).  Finally, research indicates that 
impairment in fine motor abilities increases with the progression of the disease which 
causes a decrease the IADLs, reducing independent self-care (de Paula et al., 2016).  This 
increase in impairment in IADLs is the root of the necessity for a care-giver with the 
progression of Alzheimer’s Disease. 
 
Vascular Dementia 
Vascular dementia accounts for approximately 15% of all dementia cases, and is 
the second-most diagnosed subgroup of dementia, surpassed by Alzheimer’s Disease 
(O’Brien & Thomas, 2015). Historically, uncertainties about the classification and 
diagnostic criteria for Vascular dementia have made this subgroup of dementia widely 
misunderstood. Vascular dementia is a condition in which a cerebrovascular event 
transpires, leaving behind varying levels of cognitive impairment. Because the diagnosis 
itself has the word “dementia” in its title, individuals often believe that memory 
impairment is a prominent feature of the disorder. However, O’Brien and Thomas (2015) 
posit that vascular dementia’s effect on memory varies to differing degrees and fails to 
follow the progressive pattern of Alzheimer’s, therefore, suggest the term ‘vascular 
cognitive impairment’ may encompass a more appropriate depiction of this specific 
condition. For the purpose of this paper, the terms will be used interchangeably. Vascular 
Dementia can develop due to a variety of differing vascular complications, including 
multiple cortical infarcts, lacunes, extensive white matter lesions, demyelination, gliosis, 
haemorrhagic changes, and amyloid angiopathy (O’Brien & Thomas, 2015). Because of 
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the variations of vascular events that occur, Vascular Dementia involves many avenues in 
which a diagnosis is warranted, thus creating a large accumulation of research on the 
matter, and an inconsistent neurocognitive profile. However, a diagnosis of Vascular 
Dementia can typically assume significant cognitive changes and certain neuropsychiatric 
features. 
To warrant a diagnosis of Vascular Dementia using criteria from the Diagnostic 
and Statistical Manual of Mental Disorders (DSM-5), an individual would need to display 
evidence of a significant cognitive decline in one or more cognitive domains, the deficits 
would need to interfere with independence in ADLs, the features would need to be 
consistent with a vascular etiology, there would need to be evidence of the presence of 
cerebrovascular disease, and the symptoms should not be explainable by another medical, 
mental, or brain disease/disorder (American Psychiatric Association, 2013). The 
American Psychiatric Association (2013) suggests that cognitive domains affected by 
neurocognitive impairment may include complex attention, executive function, learning 
and memory, language, perceptual motor, and social cognition. Evidence of vascular 
etiology is to be determined by either temporal relation to a cerebrovascular event or a 
decline in complex attention and frontal-executive functioning. Finally, presence of 
cerebrovascular disease is discovered through an individual’s history, a physical 
examination, and/or a form of neuroimaging to explain neurocognitive deficits (American 
Psychiatric Association, 2013).  Because of the varying vascular events that may result in 
a diagnosis of Vascular Dementia, there are an array of vascular neurocognitive profiles.  
This study focused on individuals who have a “typical” vascular neurocognitive profile, 
according to Levy and Chelune (2007), consisting of executive functioning deficits, 
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learning and memory issues, and prominent depressed mood to encompass most 
variations of Vascular Cognitive Impairment.   
A review of the literature posits deficits in executive functioning as one of the 
largest markers for a vascular neurocognitive profile (Graham et al., 2004; Jokinen et al., 
2006; Kandiah, Narasimhalu, Lee, & Chen, 2009; Levy & Chelune, 2007; Traykov et al., 
2004).  Jokinen et al. (2006) purported that executive deficits, incorporating mental 
flexibility, set shifting, response inhibition, and fluency are prominent characteristics of 
subcortical ischemic vascular dementia. Another study found that individuals with 
Vascular Dementia had a greater number of perseverations on an assessment that 
measures “stuck-in-set perseverations,” suggesting vascular etiologies result in greater 
difficulty with switching tasks and thought processes (Traykov et al., 2004). This 
presumes those affected by vascular etiology have difficulty in shifting attention toward 
new stimuli because they are fixated on previous and/or possibly absent stimuli. 
Naturally, this would create functional deficits in IADLs, as well as deficits in social and 
interpersonal interaction. Levy and Chelune (2007) suggest executive deficits as a result 
of the disruption of the frontal-subcortical circuits. The area of the brain affected by 
vascular etiology will greatly influence the way in which executive deficits occur in 
different individuals.   
In addition to executive dysfunction, individuals with Vascular Dementia or 
Vascular Cognitive Impairment also suffer from a spectrum of memory problems. 
Compared with Alzheimer’s Disease, episodic memory tends to be more intact for 
individuals diagnosed with Vascular Dementia (O'Brien et al., 2003). However, memory 
difficulties associated with Vascular Dementia often include poor performance on 
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procedural memory tasks and poor ability to maintain learning for future tasks (Levy & 
Chelune, 2007). Graham et al. (2004) also found individuals diagnosed with Vascular 
Dementia show greater deficits in semantic memory. These findings suggest individuals 
with Vascular Cognitive Impairment struggle with memory complications much like 
Alzheimer’s Disease patients; however, Vascular Cognitive Impairment typically 
manifests memory complications in relation to the location of the vascular etiology, 
producing several manifestations of memory impairment. Unfortunately, research 
findings have also indicated individuals with Vascular Dementia suffer from anosognosia 
related to their memory functioning, although the severity is less than those affected by 
Alzheimer’s Disease (Morris et al., 2016). As a result, memory impairment in Vascular 
Dementia seems to be deviant from that of Alzheimer’s Disease, but both types of 
impairments effect every-day functioning and estimation of abilities.  
To further complicate the neurocognitive profile of Vascular Dementia/Vascular 
Cognitive Impairment, patients diagnosed with the disorder often suffer from mood 
related difficulties, as well, thus creating complications differentiating pure depressive 
symptomology from objective neurodegenerative concerns or most commonly a 
combination of the two. Park et al. (2007) conducted a study in which various patients 
with subtypes of dementia were matched on gender and dementia severity, and then 
compared the rates of depression within the groups. As a result, depressive symptoms 
were common in both Vascular Dementia patients, as well as Alzheimer’s Disease 
patients; however, the patients with Vascular Dementia suffered from more depressive 
symptoms more often than that of Alzheimer’s Disease patients (Park et al., 2007).  
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Mild Cognitive Impairment 
Mild Cognitive Impairment is a construct which reflects abnormal cognitive 
performance for one’s age and accounts for 3% to 19% of the population over the age of 
65 (Gauthier et al., 2006). More specifically, the diagnostic criteria for Mild Cognitive 
Impairment consists of the following: (1) subjective memory complaint, (2) preserved 
activities of daily living, (3) intact general cognitive function, (4) memory impairment 
exceeding what would be expected for the normal aging process, and (5) no dementia 
diagnosis (Petersen et al., 1999). Subsequently, Petersen (2003), formulated three 
subtypes of Mild Cognitive Impairment, consisting of amnestic, multiple domain, and a 
single non-memory domain. The amnestic form of Mild Cognitive Impairment is the 
most common form of the diagnosis and likely results in a diagnosis of Alzheimer’s 
disease after disease progression has occurred, and involves mainly significant memory 
impairment with no impairment in other cognitive domains (Petersen, 2003). The 
multiple domain form of Mild Cognitive Impairment typically encompasses minor 
impairments in activities of daily living and other general cognitive domains, such as 
executive function and language (Petersen, 2003). Further, single, non-memory domain 
Mild Cognitive Impairment is as the name implies, consisting of impairment in a single 
cognitive domain (e.g., executive functioning, language, visuospatial processing) without 
impairment in memory functioning (Petersen, 2003). Although the subtypes are important 
for diagnostic and clinical implications, the current study engenders all subtypes of Mild 
Cognitive Impairment without subtype specification to encompass Mild Cognitive 
Impairment in relation to a subjective memory complaints profile.  
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Mild Cognitive Impairment may be comprised of different etiologies, consisting 
of either degenerative, vascular, psychiatric, or traumatic etiologies (Petersen, 2004).  
Thus, differing etiologies may result in differences in projected outcome or progression 
of Mild Cognitive Impairment and variations of subjective memory complaint or 
activities of daily living. A diagnosis of Mild Cognitive Impairment is likely to lead to 
the eventual diagnosis of dementia with the progression of the aging process, specifically, 
the diagnosis of amnestic Mild Cognitive Impairment results in the greatest association 
with transition to Alzheimer’s Disease (Busse, Hensel, Guhune, Angermeyer, & Riedel-
Heller, 2006). Due to the high association between Mild Cognitive Impairment and later 
dementia, clarity and accuracy of the diagnosis is pertinent to the treatment 
recommendations and clinical implications of the patient’s life going forward, 
accordingly, accurate profile mapping is necessary for this domain. 
To further complicate assessment and diagnosis of Mild Cognitive Impairment, it 
is often accompanied by comorbid depression, meaning it is critical to distinguish 
cognitive impairment or decline from typical cognitive insufficiencies produced by 
depression alone or if there are comorbid diagnoses occurring (Ravdin & Katzen, 2013). 
Panza et al. (2009) posit 34% of patients diagnosed with MCI have co-occurring 
depressive symptomology. Of note, the patients in this study may not have met diagnostic 
criteria for Major Depressive Disorder; however, the patients were experiencing 
clinically significant depressive symptomology. If comorbidities occur, it is possible an 
evaluator may interpret memory performance more critically than those who have a 
single diagnosis of Mild Cognitive Impairment or depression. As addressed previously, 
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the diagnostic implications for Mild Cognitive Impairment alone differ greatly than the 
diagnostic implications for depression alone or the comorbidity of the two diagnoses.  
 
Pseudodementia 
Pseudodementia is a term that signifies cognitive deficits due to the effects of 
depressive symptomology, in the absence of organic dementia. Therefore, 
Pseudodementia, as a term, can be utilized interchangeably with Depression-Related 
Cognitive Impairment, which is a more preferred term in clinical practice. Ravdin and 
Katzen (2013) posit depression in older adults living in in a community-dwelling 
population has a prevalence rate of approximately 3 to 14 percent; over the course of one 
year, 1 in 15 older adults may experience major depression. In this case, the cognitive 
decline or deficits experienced are purely caused by psychiatric illness, rather than 
dementia-related illness. Unfortunately, experiencing late-life depression increases the 
risk of later developing dementia (Ravdin & Katzen, 2013).  
The presentation of Pseudodementia has been found to produce significant 
cognitive complaints, often accruing more subjective complaints than those diagnosed 
with dementia (Siu, 1991). Further, Siu (1991) posits the reported cognitive complaints 
are often out of proportion to the level of the individual’s current functioning capabilities, 
producing a profile of catastrophizing thought-related symptomology. This would present 
as a patient reporting severe memory impairment, yet consistently engaging in everyday 
activities such as managing finances, driving independently, cooking independently, 
and/or managing medications for oneself or someone else. This is in opposition with 
those independently diagnosed with Alzheimer’s Dementia or later stages of Vascular 
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Dementia in which anosognosia impairs the patient’s insight into their current capabilities 
of independent functioning, producing fewer subjective complaints of memory 
impairment.  
Further, prominent features of Pseudodementia are shared with that of Major 
Depression and may be difficult to differentiate from early features of distinctive types of 
dementia. For example, research suggests apathy is a prominent early feature of 
Alzheimer’s Disease and is also known to be a pronounced feature of depression; 
however, there is a discrimination between apathetic syndrome in Alzheimer’s Disease 
and dysphoric mood in depression, thus creating a need for accurate assessment and 
careful dissection of hardly distinguishable symptomology (Hattori, Yoshiyama, Miura, 
& Fujie, 2010; Landes, Sperry, Strauss, & Geldmacher, 2001). Therefore, at face value, 
the two symptoms may be inseparable, but additional investigation is necessary to 
illuminate primary features of depression versus an early marker of preclinical 
Alzheimer’s Disease. As a result, the prevalence, risk factors, and clinical presentation 
associated with late-life depression advance the need for clarity in subjective memory 
complaints in patients presenting to outpatient treatment clinics for medical necessity or 
psychiatric necessity.   
 
Poor Effort 
Poor effort or malingering (or feigning; all terms are used interchangeably) can be 
defined as the intentional exaggeration of neurological and/or psychological symptoms 
for the gain of an identifiable external reward (American Psychiatric Association, 1994). 
With the advancement of the field of neuropsychology and forensic neuropsychology, 
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specifically, there has been an uptick of individuals presenting in outpatient assessment 
settings for the purpose of personal injury litigation, worker’s compensation, and other 
situations in which patients may gain financially from neuropsychiatric diagnoses (Slick, 
Sherman, & Iverson, 2010). Thus, the development of validity assessment was necessary 
to facilitate identification of feigned symptomology versus genuine neurologically 
impaired symptomology in these specific cases.  
With the need of validity assessment came the abundance of scales and tasks 
developed to highlight feigning. A list of these tasks include the Test of Memory 
Malingering (TOMM), the Structured Inventory of Malingered Symptomology (SIMS), 
the Medical Symptom Validity Test (MSVT), the Non-Verbal Medical Symptom 
Validity Test (NV-MSVT), the Word Memory Test (WMT), and the Memory Complaints 
Inventory (MCI) which is utilized in the current study. This list is not an exhaustive 
account of all measures available for validity assessment; however, it is to provide insight 
into the multiple ways in which practitioners are capable of assessing malingering in both 
performance and symptom report measures. Therefore, with the variety of measures to 
choose from, the question bodes how neuropsychologists are able to categorize patients 
into the Poor Effort subgroup in their practice.  
Diagnostic criteria for poor effort proposed by Slick et al. (2010) highlights three 
diagnoses of malingering to differentiate: Definite Malingering Neurocognitive 
Dysfunction, Probable Malingering Neurocognitive Dysfunction, and Possible 
Malingering Neurocognitive Dysfunction. All three diagnoses of malingering consist of 
four components which must be met for poor effort or malingering to be considered: (1) 
presence of a substantial external incentive, (2) evidence from neuropsychological 
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testing, (3) evidence from self-report, and (4) behaviors meeting necessary criteria are not 
accounted for by psychological, neurological, or developmental conditions (Slick et al., 
2010). In order to specify and rule out uncertainty within these criteria, the authors 
proposed that the evidence of neuropsychological testing can be comprised of a negative 
response bias, probable response bias, or a discrepancy between test data and brain 
functioning, observed behavior, collateral reports, or documented background history 
(Slick et al., 2010). Similarly, the authors detailed that evidence from self-report needs to 
encompass a discrepancy between self-reported history/symptoms and documented 
history, patterns of brain functioning, behavioral observations, collateral information, or 
exaggerated psychological dysfunction, as evidenced by a scale such as the MMPI-2-RF 
(Slick et al., 2010). For the purpose of the current study, patients who met criteria for 
Definite, Probable, and Possible Malingering of Neurocognitive Dysfunction defined by 
Slick et al. (2010) were included in the Poor Effort group for analysis.  
The current study used the reviewed neurocognitive profiles to postulate self-
reported memory impairment, employing the Memory Complaints Inventory (MCI).  
Taking into consideration the severity of Alzheimer’s Disease, consisting of significant 
cognitive deficits, anosognosia, and functional impairment, it was hypothesized that 
individuals in the Alzheimer’s Disease sample group would produce an MCI profile 
consisting of the least amount of memory complaints in relation to the subgroups being 
analyzed in this study. With respect to the severity and variations of Vascular Dementia, 
it was hypothesized that individuals in the Vascular Dementia sample group would 
produce an MCI profile consisting of more reported memory complaints than those with 
Alzheimer’s Disease, but fewer memory complaints than those diagnosed with Mild 
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Cognitive Impairment, Pseudodementia, or those found to display poor effort. Because of 
the variations in etiology and severity of Mild Cognitive Impairment, in addition to the 
high comorbidity of Depression, it was postulated individuals in the Mild Cognitive 
Impairment sample group would produce an MCI profile consisting of more reported 
memory complaints than those with Alzheimer’s Disease and Vascular Dementia, but 
fewer memory complaints than those diagnosed with Pseudodementia or found to display 
poor effort. Finally, it was proposed that the individuals in the Pseudodementia or 
Depression-Related Cognitive Impairment sample group would produce an MCI profile 
consisting of the most reported memory complaints compared to those classified in the 
Alzheimer’s Disease, Vascular Dementia, or Mild Cognitive Impairment diagnostic 
categories. Although Pseudodementia was predicted to produce the greatest number of 
overall memory complaints with respect to the dementia subgroups, the authors proposed 
that the Poor Effort subgroup would produce the greatest overall memory complaint 
profile while simultaneously producing the highest number of memory complaints on the 
imbedded Implausible memory scale of the MCI. To clarify, the current study 
hypothesized an inverse relationship of self-reported memory complaints utilizing the 
MCI and the severity of dementia diagnosis. Further, due to the literature review, the 
researchers postulated that a comorbidity of depression accompanying the primary 
dementia diagnosis would have an impact on self-reported memory complaints.  
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METHODS 
 
Participants 
Participants were selected from the archival database at CoxHealth Hospital 
Neuropsychology Services in the Midwest.  Individuals presented to the outpatient clinic 
for various concerns, including memory complaints, attentional difficulties, interpersonal 
and occupational conflicts, and neurology referrals.  Protected Health Information release 
forms (Appendix A) were signed at the time of their initial interviews, endorsing their 
results may be used in research studies. Further, this study was approved by the 
Institutional Review Board at Missouri State University, clarifying this research does not 
permit any harm to the subjects involved (see Appendix B). Those selected for inclusion 
in this project were all adults assessed at the outpatient Neuropsychology clinic who were 
administered the Memory Complaints Inventory and an individualized 
neuropsychological test battery for diagnostic purposes. Data gathered included the 
individual’s age, gender, ethnicity, handedness, education level, Memory Complaints 
Inventory results, and diagnoses. 
Two hundred forty-four (n = 244) total participants were determined as meeting 
inclusion criteria for the current study after data screening analyses. The average age was 
63.6 years (SD = 13.67; 25 – 89 years of age) and consisted of 39.75% males (n = 97) 
and 60.25% females (n = 147).  Ethnicity of the sample was 98.36% (n = 240) White, 
0.41% (n = 1) Mexican-American, 0.82% (n = 2) Native American, and 0.41% (n = 1) 
West Indian. All other ethnicities were not represented in this study due to the limited 
sample provided in the archival database from the Midwestern hospital in which data 
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were collected. Additionally, 90.98% (n = 222) of the sample was right-handed, meaning 
9.02% (n = 22) of the sample was left-handed. Table 1 depicts the complete 
demographics of the sample for the study. 
 
Table 1 
 
Sample Demographics 
  Primary Diagnostic Category  
 
Alzheimer’s 
Disease 
Vascular 
Dementia 
Mild 
Cognitive 
Impairment 
Pseudo-
dementia 
Poor Effort 
Total n 21 33 88 53 49 
Age M (SD) 77.00 (5.61) 75.94 (8.01) 66.98 (8.78) 57.85 (12.77) 49.69 (11.62) 
Gender      
     Male 9 14 45 11 18 
     Female 12 19 43 42 31 
Self-Identified Ethnicity      
     White 21 31 88 51 49 
     Mexican American -- -- -- 1 -- 
     Native American -- 1 -- 1 -- 
     West Indian -- 1 -- -- -- 
Education      
     7-11 Years 4 6 10 10 9 
     High School Graduate 12 20 26 21 17 
     1 Year College 1 2 11 4 4 
     2 Years College 1 1 7 6 6 
     3 Years College -- 1 1 2 5 
     College Degree 2 1 13 7 7 
     Master’s Degree 1 1 15 2 1 
     Post Master’s Work -- -- 3 1 -- 
     Doctoral Degree -- 1 2 -- -- 
Handedness      
     Right 12 33 80 49 43 
     Left 4 -- 8 4 6 
Note: Ethnicity was self-identified; Education was separated by categories imbedded in the Memory 
Complaints Inventory 
 
 
Materials 
The Memory Complaints Inventory (Green, 2004) was embedded in each 
individual’s neuropsychological assessment battery conducted in the outpatient clinic.  It 
was designed to measure memory complaints by categorizing the complaints into nine 
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separate scales, consisting of General Memory Problems (GMP), Numerical Information 
Processing and Memory Problems (NIP), Visual-Spatial Memory Problems (VSMP), 
Verbal Memory Problems (VMP), Pain Interferes with Memory (PIM), Memory 
Interferes with Work (MIW), Impairment of Remote Memory (IRM), Amnesia for 
Complex Behavior (ACB), and Amnesia for Antisocial Behavior (AAB). Participants are 
asked how true a statement is for them within the last month.  The Memory Complaints 
Inventory is comprised of 58 Likert-type items on a zero- to four-point scale ranging 
from “not at all true” to “extremely true.”  The first seven scales make up the Plausible 
memory items, indicating true memory impairment, while the last two scales, ACB and 
AAB, present the Implausible memory complaints category which may indicate symptom 
validity concerns when the Implausible scales are elevated. The MCI has high reliability 
( = 0.93) for all nine scales, as well as high internal reliability, assessed by split-thirds 
reliability standards.  High scores on the first seven scales represent one’s subjective 
memory complaints are greater than that of a normal population, while high scores on the 
ACB and AAB scales suggest an exaggerated subjective memory experience. 
 
Procedure 
Data were collected over a two-year period in an outpatient Neuropsychology 
Services Clinic.  Every patient who presented to the outpatient clinic and complained of 
memory complaints was administered the MCI as a part of their Neuropsychological 
testing battery.  The MCI was randomly administered throughout the course of the 
assessment process.  
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Data Screening 
All data were screened for accuracy and missing data. Participants with more than 
5% missing data (i.e., 2 or more items) were excluded, as Tabachnick and Fidell (2012) 
have suggested that 5% or less of missing data may be safely filled in with minimal 
effects on hypothesis testing. In this particular dataset, there was no missing data, as all 
participants were required to complete every question to finish the MCI in their 
neuropsychological testing batteries. The final sample sizes, as shown in Table 1 
remained sufficient for analyses described below. Of note, however, is the Alzheimer’s 
Disease group, of which failed to meet the central limit theorem necessary for powerful 
analyses, thus, the results of the Alzheimer’s Disease group analysis should be interpreted 
with caution, as it may represent an overestimation or underestimation of scores that 
would be seen with a larger sample size. 
Next, each dataset was examined for multivariate outliers using Mahalanobis 
distance (Tabachnick & Fidell, 2012). As described in Tabachnick and Fidell (2012), 
Mahalanobis values were calculated for each participant based on their answer choice 
patterns for each of the fifty-eight questions. These D values are compared to a χ2(58) 
p<.001 = 32.91, and observations with D values greater than this score were counted as 
outliers. For this dataset, there were four outliers that met the Mahalanobis distance 
criteria and were excluded from this analysis. This analysis is similar to using a z-score 
criterion of three standard deviations away from the mean.  
Finally, the dataset was screened for multivariate assumptions of additivity, 
linearity, normality, homogeneity, and homoscedasticity. There were high correlations 
between the General Memory Problems (GMP) subscale and the Plausible imbedded 
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validity scale (r = .93), as well as the GMP subscale and the Overall score (r = .92) on the 
MCI. Additionally, the Plausible scale was highly correlated with the Verbal Memory 
Problems (VMP) subscale (r = .92) and the Memory Interferes with Work (MIW) 
subscale (r = .91). While high correlations between subscales on a measure typically 
indicate poor measure structure and collapsible subscales, in this case, we would 
anticipate high correlations among the GMP, VMP, and MIW subscales with the 
Plausible scale and Overall score due to the impact these difficulties have on individuals 
in everyday life and the way in which the MCI was created. For example, General 
Memory Problems should weigh heavily into the Plausible validity scale and Overall 
score, meaning the General Memory Problems reported represent genuine impairment 
and reflect overarching self-identified impairment derived from the Overall total score. 
Further, the Amnesia for Complex Behavior (ACB) subscale was highly correlated with 
the Implausible imbedded validity scale (r = .94) and the Overall total score (r = .91). 
Again, these correlations are anticipated since the Implausible validity scale was derived 
from scores on the ACB and AAB (Amnesia for Antisocial Behavior), which ultimately 
impact Overall total score by self-identified impairment. Finally, large correlations were 
observed on the Overall total score compared with both the Plausible (r = .98) and 
Implausible (r = .93) imbedded validity measures, commensurate with expectation 
considering the development of the scale referenced previously.  
Data met the assumption for linearity, and data were only slightly kurtotic 
meeting the assumption for normality. Additionally, the assumptions of homogeneity and 
homoscedasticity were met for the overall dataset.  
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Data Analysis 
One-way between-subjects analysis of variance (ANOVA) statistics were 
conducted to compare the effect of dementia diagnosis on self-reported memory 
complaints for each subscale of the MCI. Thus, twelve one-way ANOVAs were utilized 
to encompass all subscales of the MCI, including overall score for memory complaints 
and the plausible and implausible validity scales imbedded into the MCI. Pairwise 
independent t-tests were conducted to compare the distinct differences between dementia 
subgroups with Bonferroni corrections to account for the inflation of type I error. 
Cohen’s d effect size analyses were run for every comparison to provide additional 
evidentiary value and to provide a practical source of significance in addition to the 
traditional view of statistical significance of p-values. Further, a 3 (diagnostic category: 
Vascular Dementia vs. Mild Cognitive Impairment vs. Poor Effort) X 2 (presence 
secondary diagnosis of depression: secondary depression vs. no secondary depression) 
between-subjects ANOVA was conducted to determine if a secondary diagnosis of 
depression had an interaction with participants’ overall score on the MCI, as postulated 
by the researchers. The Alzheimer’s Disease diagnostic condition was omitted from this 
two-factor ANOVA due to the limited number of Alzheimer’s participants concurringly 
diagnosed with depression in this sample (n = 7), resulting in low statistical power for 
this analysis, thus not reasonable to evaluate. Further, the Pseudodementia group was 
omitted from the two-factor ANOVA due to depression as the primary diagnosis rather 
than the secondary diagnosis, as a result of the neuropsychological profile associated with 
Pseudodementia. 
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RESULTS 
 
Data from adults presenting to a neuropsychology outpatient clinic were analyzed 
to determine differences in memory complaint profiles on the Memory Complaints 
Inventory (MCI). Five subgroups of patients were derived from their primary diagnosis in 
the archives, consisting of Alzheimer’s Disease patients, Vascular Dementia patients, 
Mild Cognitive Impairment patients, Pseudodementia patients, and patients who 
presented to the clinic for memory complaints that were considered to produce a profile 
consistent with poor effort on their individualized neuropsychological testing battery. The 
researchers hypothesized an inverse relationship of memory complaints and diagnostic 
severity of dementia. Specifically, it was postulated the Alzheimer’s Disease patients 
would produce the least amount of memory complaints based on the literature of the 
typical neurocognitive profile. It was predicted Vascular Dementia patients would present 
with the second lowest number of overall memory complaints on the MCI. The Mild 
Cognitive Impairment group was hypothesized to report a larger amount of memory 
complaints on the MCI relative to Vascular Dementia patients, yet a lower number of 
memory complaints than the Pseudodementia group. Finally, the Pseudodementia 
patients were predicted to encompass the greatest amount of memory complaints relative 
to the dementia subgroups; however, the Poor Effort subset of patients were hypothesized 
to surpass all dementia diagnostic categories and produce the greatest number of overall 
memory complaints on the MCI while also elevating the imbedded validity scales.   
The hypotheses for the study were tested using one-way between-subjects 
ANOVAs to compare differences in scores between primary diagnostic groups on all nine 
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subscales of the MCI, the overall number of memory complaints, and the Plausible and 
Implausible imbedded validity scales. The results of the 12 one-way ANOVAs can be 
seen in Table 2, below. Welch corrections were utilized for the ANOVAs in which 
Levene’s test of homogeneity was significant. There was a significant effect of primary 
dementia diagnosis on overall memory complaints F(4, 91.11) = 41.02, p < .001, η2= .74. 
Post hoc independent t-tests with a Bonferroni correction were used to find differences in 
overall memory scores between each primary diagnosis. For overall memory scores, 
Alzheimer’s Disease significantly differed from the Pseudodementia group (p = .002, d = 
0.93) and the Poor Effort group (p < .001, d = 2.58) with large effect sizes for both 
significant differences. Pseudodementia was significantly different from the Poor Effort 
group (p < .001, d = 1.27) with regard to overall memory complaints. The Mild Cognitive 
Impairment group significantly differed in overall memory complaints from the Poor 
Effort group (p < .001, d = 1.86), and the Poor Effort group significantly differed from 
the Vascular Dementia group (p < .001, d = 2.03). All post hoc comparisons can be found 
in Appendix C. The data obtained followed the trend predicted in that Alzheimer’s 
Disease patients reported the least amount of overall memory complaints on the MCI, 
while those in the Poor Effort group reported the greatest amount of overall memory 
complaints, in a step-wise progression with a decrease of severity in diagnosis.  
Primary dementia diagnosis also resulted in significant differences on the 
Plausible memory scale F(4, 90.39) = 41.78, p < .001, η2= .75, which represents one of 
the imbedded validity measures of the MCI and alludes that patients are being honest in 
the memory complaints they are reporting. Post hoc independent t-tests with a Bonferroni 
correction were utilized to examine the differences in Plausible memory subscale scores 
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between each primary diagnosis. Significant results were found when comparing 
Alzheimer’s Disease to Pseudodementia (p = .002, d = 0.94), Alzheimer’s Disease to 
Poor Effort (p < .001, d = 2.65), Pseudodementia to Poor Effort (p < .001, d = 1.27), 
Pseudodementia to Vascular Dementia (p = .05, d = 0.58), Mild Cognitive Impairment to 
Poor Effort (p < .001, d = 1.80), and Poor Effort to Vascular Dementia (p < .001, d = 
2.08). All significant post hoc comparisons with the Plausible memory subscale resulted 
in large effect sizes with the exception of the comparison of Pseudodementia to Vascular 
Dementia, of which resulted in a medium effect. 
Finally, primary dementia diagnosis had significant effects on the Implausible 
memory scale of the MCI F(4, 92.31) = 23.43, p < .001, η2= .64, which represents the 
second imbedded validity scale and indicates patients are likely not being honest in their 
memory complaint presentation. Again, post hoc independent t-tests with a Bonferroni 
correction were conducted to examine the differences in Implausible memory subscale 
scores between each primary dementia diagnosis. Significant results were found when 
comparing Alzheimer’s Disease to Pseudodementia (p = .03, d = 0.80), Alzheimer’s 
Disease to Poor Effort (p < .001, d = 1.85), Pseudodementia to Poor Effort (p < .001, d = 
1.04), Mild Cognitive Impairment to Poor Effort (p < .001, d = 1.57), and Poor Effort to 
Vascular Dementia (p < .001, d = 1.50). All significant post hoc comparisons with the 
Plausible memory subscale resulted in large effect sizes.  
A general trend is seen in most of the nine subscales in Table 2 in which 
Alzheimer’s Disease patients reported the least amount of memory complaints, while the 
Poor Effort group reported the greatest amount of memory complaints.
  
Table 2 
 
Primary Diagnosis Effects on Memory Complaints Inventory Subscales 
 
Alzheimer’
s Disease M 
(SD) 
Vascular 
Dementia M 
(SD) 
Mild 
Cognitive 
Impairment M 
(SD) 
Pseudo-
dementia M 
(SD) 
Poor Effort 
M (SD) 
F(df,df) = F p Ƞ2 
n 21 33 88 53 49    
GMP 4.08 (3.14) 6.06 (4.65) 6.70 (4.78) 8.87 (5.68) 15.65 (5.33) F(4, 90.06) = 36.08 <.001* .69* 
NIP 6.00 (3.52) 7.21 (4.26) 7.67 (4.72) 9.35 (5.67) 15.31 (4.87) F(1, 239) = 692.20 <.001* .74* 
VSMP 4.10 (3.03) 4.30 (3.79) 4.80 (3.90) 5.30 (4.14) 9.71 (3.97) F(1, 239) = 409.10 <.001* .63* 
VMP 4.62 (2.52) 6.27 (4.35) 7.66 (4.35) 9.68 (5.09) 13.73 (3.55) F(4, 91.21) = 41.77 <.001* .76* 
PIM 1.14 (1.85) 1.12 (1.62) 2.17 (2.76) 3.06 (3.46) 5.92 (3.98) F(4, 91.88) = 16.35 <.001* .39* 
MIW 3.57 (2.99) 6.15 (4.21) 6.24 (5.55) 8.49 (6.14) 13.96 (4.48) F(4, 93.33) = 36.03 <.001* .64* 
IRM 3.19 (2.77) 5.42 (3.90) 5.34 (4.46) 7.09 (6.22) 11.45 (6.76) F(4, 92.03) = 13.71 <.001* .56* 
ACB 5.48 (3.82) 7.06 (5.59) 6.99 (6.63) 10.49 (7.61) 18.47 (8.33) F(4, 93) = 22.93 <.001* .61* 
AAB 0.90 (1.22) 1.27 (2.07) 1.31 (2.23) 1.34 (2.02) 3.55 (3.32) F(4, 92.71) = 5.97 <.001* .29* 
Plaus 3.91 (2.34) 5.19 (3.40) 5.87 (3.68) 7.46 (4.20) 12.38 (3.49) F(4, 90.39) = 41.78 <.001* .75* 
Implaus 3.19 (2.23) 4.59 (3.37) 4.55 (3.77) 6.31 (4.37) 11.16 (4.93) F(4, 92.31) = 23.43 <.001* .64* 
Overall 3.67 (2.16) 4.99 (3.23) 5.43 (3.50) 7.07 (4.10) 11.97 (3.56) F(4, 91.11) = 41.02 <.001* .74* 
Note: GMP = General Memory Problems; NIP = Numerical Information Processing; VSMP = Visual-Spatial Memory Problems; VMP 
= Verbal Memory Problems; PIM = Pain Interferes with Memory; MIW = Memory Interferes with Work; IRM = Impairment of Remote 
Memory; ACB = Amnesia for Complex Behavior; AAB = Amnesia for Antisocial Behavior; Plaus = Plausible Memory Complaints; 
Implaus = Implausible Memory Complaints; * indicates significance 
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Additionally, a 3 (diagnostic category: Vascular Dementia vs. Mild Cognitive 
Impairment vs. Poor Effort) X 2 (presence secondary diagnosis of depression: secondary 
depression vs. no secondary depression) between-subjects ANOVA was conducted to 
determine if a secondary diagnosis of depression had an interaction with participants’ 
overall score on the MCI. The Alzheimer’s Disease patients were omitted from this 
analysis due to the small sample size who were concurrently diagnosed with depression. 
Table 3 below displays the results of the analysis.  
 
Table 3 
 
Interaction of Secondary Diagnosis of Depression on Overall Memory 
Complaints 
 F(df, df) = F p Ƞ2 
Overall F(1, 164) = 657.14 <.001* .80* 
    
Primary Diagnosis F(2, 164) = 63.89 <.001* .44* 
    
Secondary Diagnosis of Depression F(1, 164) = 0.85 .36 .01 
    
Primary and Secondary Interaction F(2, 164) = 0.15 .86 .002 
Note: * denotes significance 
 
The overall 3 X 2 between-subjects ANOVA was significant F(1, 164) = 657.14, 
p < .001, η2= .80, with a large effect. The data suggests there is no interaction between a 
secondary diagnosis of depression and primary diagnosis of dementia on overall memory 
complaints reported on the MCI F(2, 164) = 0.15, p < .36, η2= .01; however, the analysis 
indicates a primary diagnosis of dementia is significant on overall memory complaints 
F(2, 164) = 63.89, p < .001, η2= .44, with a large effect, which is explained in the primary 
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results, above. Therefore, post hoc analyses were not conducted due to non-significant 
results of a secondary diagnosis of depression. 
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DISCUSSION 
 
As the field of Neuropsychology has progressed, our research and understanding 
of the neurocognitive disorders has also progressed. Yet, there is often unclear distinction 
between the neurodegenerative disorders and their objective presentations in a general 
practice setting. Many researchers have endeavored to make distinctions in behavioral 
presentations of dementia and objective test data that facilitate general medical practice 
and comprise our neuropsychological profiles; however, the use of short questionnaires 
and scores on the commonly used Mini Mental Status Exam (MMSE), Saint Louis 
University Mental Status (SLUMS) exam, or the Montreal Cognitive Assessment 
(MOCA) rarely provide insight into diagnostic specificity of dementia. The lack of 
available specificity in generalized medical practice assessments may often result in poor 
treatment modalities since the differentiation of diagnosis has a large impact on prognosis 
and interpersonal relationships. This study highlights the Memory Complaints Inventory 
(MCI) as a tool to be utilized in general practice to provide insight into diagnostic 
specificity of dementia while also differentiating from those who are misrepresenting 
themselves and offering poor effort for a multitude of reasons.  
Based on the review of the literature, the researchers hypothesized an inverse 
relationship between diagnostic severity of dementia and overall scores on the MCI, 
suggesting a pattern in which Alzheimer’s patients would report the fewest memory 
complaints due to the association of anosognosia (Clare et al., 2004; Ecklund-Johnson & 
Torres, 2005; Lehrner et al., 2015). Vascular Dementia patients were predicted to report 
more overall memory complaints than Alzheimer’s patients, yet fewer complaints than 
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individuals diagnosed with Mild Cognitive Impairment, Pseudodementia, or those 
meeting the requirements for Poor Effort. The researchers also proposed Mild Cognitive 
Impairment patients would produce a profile of memory complaints greater than those 
with Vascular Dementia and less than those with Pseudodementia or Poor Effort; while, 
Pseudodementia patients were to represent the greatest number of memory complaints in 
the dementia category. Poor Effort patients were postulated to produce the greatest 
number of memory complaints overall and to significantly deviate in responses on the 
Implausible imbedded validity scale. Finally, patients of whom received a secondary 
diagnosis of depression were ascertained to produce significantly different results on the 
Overall scores of the MCI. 
Significant results were found on all one-way between-subjects ANOVAs, as seen 
in Table 2, which supports the idea that individuals of different subgroups of dementia 
produce statistically different and practically different profiles with regard to their self-
reported memory complaints. Although the predicted trend was met, there were not 
significant differences between all subgroups, suggesting the differences in self-reported 
memory complaints may not be as substantial as the researchers first predicted. It appears 
the greatest difference can be found between the primary dementia diagnoses and the 
Poor Effort group with regard to overall memory complaints, as the Poor Effort group 
was found to significantly differ from all dementia subgroups with large effect sizes. In 
addition, the Poor Effort subgroup significantly deviated from all other dementia 
subgroups on the Implausible validity scale of the MCI. These findings further support 
the utilization of the Memory Complaints Inventory in its intended use as a symptom 
validity scale (Green, 2004), even in populations with neurodegenerative disorders.  
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Additionally, since a plethora of authors suggest an association of depression with 
all of the dementia subgroups being tested in the current study (Park et al., 2007; Payne et 
al., 1998; Ravdin & Katzen, 2013; Starkstein et al., 2005), a two-way between-subjects 
ANOVA was conducted to test the theory that a comorbid diagnosis of depression would 
significantly impact overall self-reported memory complaints. The results of this analysis 
were nonsignificant and may indicate that although depression is often a concurring 
factor among the dementia populations, it may not be impacting the perception of 
patients’ memory more than the genuine neurological impairment patients experience as 
a result of a neurodegenerative disorder. This finding is particularly important since the 
Pseudodementia subgroup produced a memory complaints profile which consisted of a 
higher number of overall memory complaints than all other dementia subgroups 
(Alzheimer’s Disease, Vascular Dementia, and Mild Cognitive Impairment), meaning 
depression as a single occurring construct substantially impacts one’s view of their 
overall memory functioning; though, concurrently with a primary diagnosis of dementia, 
the effects of depression dissipate.  
This study was conducted on adult outpatients from a Midwestern hospital in 
which 98% of the sample was white.  It would be advantageous to conduct the same 
research utilizing a more diverse sample from across the United States to replicate the 
results found in this study. Further, the Alzheimer’s Disease group was comprised of only 
21 patients, thus under-powering the results of this specific subgroup. A dataset 
containing more Alzheimer’s Disease patients would add to the robustness of the results 
found in the current study. Consistent with the Alzheimer’s sample limitation, the sample 
of comorbidity of depression with Alzheimer’s Disease was too small to include in the 
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two-way analysis, thus leaving the question of depression impacting overall memory 
complaints in Alzheimer’s patients unanswered. Overall, future research differentiating 
self-reported memory complaints in dementia populations should consist of larger sample 
sizes, including those who obtained a secondary diagnosis of depression.  
Future research with the Memory Complaints Inventory would be advantageous 
in comparison with performance validity tests (PVTs), as well as performance on 
objective memory measures, such as the California Verbal Learning Test (CVLT), the 
Hopkins Verbal Learning Test (HVLT), and the Repeatable Battery for the Assessment 
of Neuropsychological Status (RBANS) to investigate differences in subjective memory 
complaints and objective memory performance, rather than diagnostic outcome, which 
was the focus of the current study.  
With the addition of further support of the results found in this study with a 
variety of dementia patient samples, accurate genuine memory impairment profiles can 
be developed and utilized in general practice settings to facilitate more effective 
treatment planning and prognostic descriptions given to patients and loved ones. The 
utilization of the MCI in general practice settings surpasses other measures of self-
reported memory complaints due to its added value of the imbedded symptom validity 
scales, indicating its complementary value in quick assessment scenarios.    
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APPENDIX C 
 
Post Hoc Comparisons 
Appendix C-1 
 
Post Hoc Comparison of Alzheimer’s Disease and 
Pseudodementia 
DV Group 1 Group 2 p d 
GMP AD Pseudo .002* 0.95*** 
NIP AD Pseudo .08 0.65** 
VSMP AD Pseudo 1.00 0.31* 
VMP AD Pseudo <.001* 1.12*** 
PIM AD Pseudo .15 0.62** 
MIW AD Pseudo .003* 0.90*** 
IRM AD Pseudo .04* 0.71** 
ACB AD Pseudo .05* 0.74** 
AAB AD Pseudo 1.00 0.24* 
Plausible AD Pseudo .002* 0.94*** 
Implausible AD Pseudo .03* 0.80*** 
Overall AD Pseudo .002* 0.93*** 
Note: * indicates statistical significance for p-values; * indicates 
small effect sizes, ** indicates medium effect sizes, and *** 
indicates large effect sizes 
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Appendix C-2 
 
Post Hoc Comparison of Alzheimer’s Disease and Mild Cognitive 
Impairment 
DV Group 1 Group 2 p d 
GMP AD Mild CI .29 0.59** 
NIP AD Mild CI 1.00 0.37* 
VSMP AD Mild CI 1.00 0.19 
VMP AD Mild CI .04* 0.75** 
PIM AD Mild CI 1.00 0.39 
MIW AD Mild CI .34 0.52** 
IRM AD Mild CI .93 0.51** 
ACB AD Mild CI 1.00 0.24* 
AAB AD Mild CI 1.00 0.20* 
Plausible AD Mild CI .27 0.56** 
Implausible AD Mild CI 1.00 0.38* 
Overall AD Mild CI .41 0.53** 
Note: * indicates statistical significance for p-values; * indicates 
small effect sizes, ** indicates medium effect sizes, and *** 
indicates large effect sizes 
 
Appendix C-3 
 
Post Hoc Comparison of Alzheimer’s Disease and Poor Effort 
DV Group 1 Group 2 p d 
GMP AD PE <.001* 2.42*** 
NIP AD PE <.001* 2.06*** 
VSMP AD PE <.001* 1.51*** 
VMP AD PE <.001* 2.78*** 
PIM AD PE <.001* 1.37*** 
MIW AD PE <.001* 2.54*** 
IRM AD PE <.001* 1.41*** 
ACB AD PE <.001* 1.78*** 
AAB AD PE <.001* 0.92*** 
Plausible AD PE <.001* 2.65*** 
Implausible AD PE <.001* 1.85*** 
Overall AD PE <.001* 2.58*** 
Note: * indicates statistical significance for p-values; * indicates 
small effect sizes, ** indicates medium effect sizes, and *** 
indicates large effect sizes 
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Appendix C-4 
 
Post Hoc Comparison of Alzheimer’s Disease and Vascular 
Dementia 
DV Group 1 Group 2 p d 
GMP AD VD 1.00 0.49* 
NIP AD VD 1.00 0.30* 
VSMP AD VD 1.00 0.06 
VMP AD VD 1.00 0.44* 
PIM AD VD 1.00 0.01 
MIW AD VD .74 0.68** 
IRM AD VD 1.00 0.64** 
ACB AD VD 1.00 0.32* 
AAB AD VD 1.00 0.21* 
Plausible AD VD 1.00 0.42* 
Implausible AD VD 1.00 0.47* 
Overall AD VD 1.00 0.46* 
Note: * indicates statistical significance for p-values; * indicates 
small effect sizes, ** indicates medium effect sizes, and *** 
indicates large effect sizes 
 
Appendix C-5 
 
Post Hoc Comparison of Pseudodementia and Mild Cognitive 
Impairment 
DV Group 1 Group 2 p d 
GMP Pseudo Mild CI .13 0.42* 
NIP Pseudo Mild CI .46 0.33* 
VSMP Pseudo Mild CI 1.00 0.13 
VMP Pseudo Mild CI .07 0.44* 
PIM Pseudo Mild CI .94 0.29* 
MIW Pseudo Mild CI .13 0.39* 
IRM Pseudo Mild CI .56 0.34* 
ACB Pseudo Mild CI .04* 0.50** 
AAB Pseudo Mild CI 1.00 0.01 
Plausible Pseudo Mild CI .13 0.41* 
Implausible Pseudo Mild CI .12 0.44* 
Overall Pseudo Mild CI .08 0.44* 
Note: * indicates statistical significance for p-values; * indicates 
small effect sizes, ** indicates medium effect sizes, and *** 
indicates large effect sizes 
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Appendix C-7 
 
Post Hoc Comparison of Pseudodementia and Poor Vascular 
Dementia 
DV Group 1 Group 2 p d 
GMP Pseudo VD .12 0.53** 
NIP Pseudo VD .46 0.42* 
VSMP Pseudo VD 1.00 0.25* 
VMP Pseudo VD .004* 0.71** 
PIM Pseudo VD .04* 0.67** 
MIW Pseudo VD .42 0.43* 
IRM Pseudo VD 1.00 0.31* 
ACB Pseudo VD .27 0.50** 
AAB Pseudo VD 1.00 0.03 
Plausible Pseudo VD .05* 0.58** 
Implausible Pseudo VD .55 0.43* 
Overall Pseudo VD .08 0.55** 
Note: * indicates statistical significance for p-values; * indicates 
small effect sizes, ** indicates medium effect sizes, and *** 
indicates large effect sizes 
Appendix C-6 
 
Post Hoc Comparison of Pseudodementia and Poor Effort 
DV Group 1 Group 2 p d 
GMP Pseudo PE <.001* 1.23*** 
NIP Pseudo PE <.001* 1.12*** 
VSMP Pseudo PE <.001* 1.09*** 
VMP Pseudo PE <.001* 0.92*** 
PIM Pseudo PE <.001* 0.77** 
MIW Pseudo PE <.001* 1.01*** 
IRM Pseudo PE <.001* 0.67** 
ACB Pseudo PE <.001* 1.00*** 
AAB Pseudo PE <.001* 0.81*** 
Plausible Pseudo PE <.001* 1.27*** 
Implausible Pseudo PE <.001* 1.04*** 
Overall Pseudo PE <.001* 1.27*** 
Note: * indicates statistical significance for p-values; * indicates 
small effect sizes, ** indicates medium effect sizes, and *** 
indicates large effect sizes 
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Appendix C-9 
 
Post Hoc Comparison of Mild Cognitive Impairment and 
Vascular Dementia 
DV Group 1 Group 2 p d 
GMP Mild CI VD 1.00 0.13 
NIP Mild CI VD 1.00 0.10 
VSMP Mild CI VD 1.00 0.13 
VMP Mild CI VD 1.00 0.32* 
PIM Mild CI VD .92 0.42* 
MIW Mild CI VD 1.00 0.02 
IRM Mild CI VD 1.00 0.02 
ACB Mild CI VD 1.00 0.01 
AAB Mild CI VD 1.00 0.02 
Plausible Mild CI VD 1.00 0.19 
Implausible Mild CI VD 1.00 0.01 
Overall Mild CI VD 1.00 0.13 
Note: * indicates statistical significance for p-values; * indicates 
small effect sizes, ** indicates medium effect sizes, and *** 
indicates large effect sizes 
Appendix C-8 
 
Post Hoc Comparison of Mild Cognitive Impairment and Poor 
Effort 
DV Group 1 Group 2 p d 
GMP Mild CI PE <.001* 1.8*** 
NIP Mild CI PE <.001* 1.6*** 
VSMP Mild CI PE <.001* 1.25*** 
VMP Mild CI PE <.001* 1.49*** 
PIM Mild CI PE <.001* 1.16*** 
MIW Mild CI PE <.001* 1.49*** 
IRM Mild CI PE <.001* 1.13*** 
ACB Mild CI PE <.001* 1.58*** 
AAB Mild CI PE <.001* 0.84*** 
Plausible Mild CI PE <.001* 1.80*** 
Implausible Mild CI PE <.001* 1.57*** 
Overall Mild CI PE <.001* 1.86*** 
Note: * indicates statistical significance for p-values; * indicates 
small effect sizes, ** indicates medium effect sizes, and *** 
indicates large effect sizes 
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Appendix C-10 
 
Post Hoc Comparison of Poor Effort  and Vascular Dementia 
DV Group 1 Group 2 p d 
GMP PE VD <.001* 1.90*** 
NIP PE VD <.001* 1.78*** 
VSMP PE VD <.001* 1.39*** 
VMP PE VD <.001* 1.92*** 
PIM PE VD <.001* 1.48*** 
MIW PE VD <.001* 1.79*** 
IRM PE VD <.001* 1.04*** 
ACB PE VD <.001* 1.55*** 
AAB PE VD <.001* 0.79** 
Plausible PE VD <.001* 2.08*** 
Implausible PE VD <.001* 1.50*** 
Overall PE VD <.001* 2.03*** 
Note: * indicates statistical significance for p-values; * indicates 
small effect sizes, ** indicates medium effect sizes, and *** 
indicates large effect sizes 
 
